Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Campylobacter Jejuni Infection”

9 trials

Showing 9 of 9 results

Early research (Phase 1)Study completedNCT05500417
What this trial is testing

Safety and Immunogenicity of CJCV2 With and Without ALFQ

Who this might be right for
Campylobacter Infection
National Institute of Allergy and Infectious Diseases (NIAID) 59
Early research (Phase 1)Study completedNCT04098263
What this trial is testing

Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers

Who this might be right for
Campylobacter Jejuni Infection
Lumen Bioscience, Inc. 21
Early research (Phase 1)UnknownNCT01048112
What this trial is testing

Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection

Who this might be right for
Campylobacter Infections
University of Vermont 16
Testing effectiveness (Phase 2)UnknownNCT00859716
What this trial is testing

ACE393-103 Vaccination Challenge Study

Who this might be right for
Campylobacter Infection
TD Vaccines A/S 72
Early research (Phase 1)Study completedNCT02067676
What this trial is testing

Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea

Who this might be right for
Campylobacter Infection
U.S. Army Medical Research and Development Command 48
Testing effectiveness (Phase 2)Study completedNCT04182490
What this trial is testing

LMN-101 in a Campylobacter Human Challenge Model

Who this might be right for
Campylobacter Infections
Lumen Bioscience, Inc. 42
Large-scale testing (Phase 3)Study completedNCT02280044
What this trial is testing

Efficacy of Rifaximin in Preventing Campylobacteriosis

Who this might be right for
DysenteryDiarrheaEnteric Campylobacteriosis
Johns Hopkins Bloomberg School of Public Health 30
Early research (Phase 1)UnknownNCT00434798
What this trial is testing

Campylobacter Jejuni Challenge Model Development: Dose Ranging Study

Who this might be right for
Campylobacter Infections
University of Vermont 50
Not applicableUnknownNCT02040922
What this trial is testing

Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota

Who this might be right for
Campylobacter InfectionsIrritable Bowel Syndrome
University of Nottingham 450

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation